• Cellvizio®
    • Overview
    • Education
    • Economics
  • Indications
    • Gastroenterology
      • Barrett’s Esophagus
      • Pancreatic Cysts
      • Gastric Disease
      • Inflammatory Bowel Diseases
      • Irritable Bowel Syndrome – Food Intolerance
      • Bilio-Pancreatic Strictures
      • Colorectal Lesions
    • Pulmonology
      • Lung Nodules
      • Lung Transplant
    • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial Network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • US
    • INT
    • FR
Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

by Elizabeth | Feb 23, 2026 | News

These clearances enable the commercialization of Cellvizio® in two major markets and accelerate the Group’s international expansion  First order for the next-generation Cellvizio® (Gen 3) platform received from Bern University Hospital, dedicated to functional...
BFM Business – Value Added: They Like Mauna Kea Technologies – 02/16

BFM Business – Value Added: They Like Mauna Kea Technologies – 02/16

by Elizabeth | Feb 17, 2026 | Press Coverage, Press Coverage

Mathias Pecqueur, French Small Caps Manager and President of Maitice Gestion, discussed Mauna Kea Technologies on the program BFM Bourse, hosted by Guillaume Sommerer. See the full clip here
Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States

Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States

by Elizabeth | Feb 4, 2026 | News

Building on Strong 2025 Momentum with Accelerated Sales Growth in Pancreatic Cysts & €1M Milestone for CellTolerance® Appointment of Benoit Chardon as Fractional Chief Commercial Officer to Lead Global Scale-Up of CellTolerance® Outside the United States...
United European Gastroenterology (UEG) Week 2026 Barcelona, Spain

United European Gastroenterology (UEG) Week 2026 Barcelona, Spain

by Elizabeth | Jan 29, 2026 | Events

United European Gastroenterology (UEG) Week is the largest and most prestigious GI meeting in Europe. It combines world class scientific research, invited lectures by leading minds in gastroenterology and an excellent Postgraduate Teaching Programme....
American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course 2026

American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course 2026

by Elizabeth | Jan 29, 2026 | Events

The American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course in 2026, a premier clinical GI event, will be held in Nashville, Tennessee, at the Music City Center from October 9-14, 2026. To learn more, click here.
« Older Entries
Next Entries »

Articles récents

  • Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts 
  • Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth 
  • Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity
  • Mauna Kea Technologies Secures €4.0M Shareholder Loan Agreement to Strengthen Liquidity and Fund Organic Growth
  • Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Cookie policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}